Oncodesign Precision Medicine
ALOPM.PA
#9780
Rank
NZ$32.57 M
Marketcap
$1.64
Share price
-8.44%
Change (1 day)
-49.09%
Change (1 year)

P/S ratio for Oncodesign Precision Medicine (ALOPM.PA)

P/S ratio at the end of 2023: 28.0

According to Oncodesign Precision Medicine's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.52. At the end of 2023 the company had a P/S ratio of 28.0.

P/S ratio history for Oncodesign Precision Medicine from 2022 to 2023

PS ratio at the end of each year

Year P/S ratio Change
202328.0691.65%
20223.53